Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19-Experience and Lessons from the SARS Epidemic.
Reads0
Chats0
TLDR
In this article, the authors provide a reference for health care providers in coronavirus disease 2019 endemic countries and regions, especially with respect to the pros and cons of corticosteroid use in the treatment of patients with COVID-19.Abstract:
Summary: The recent outbreak of coronavirus disease 2019 (COVID-19) has become a global epidemic. Corticosteroids have been widely used in the treatment of severe acute respiratory syndrome (SARS), and the pathological findings seen in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are very similar to those observed in severe acute respiratory syndrome-related coronavirus (SARS-CoV) infection. However, the long-term use of corticosteroids (especially at high doses) is associated with potentially serious adverse events, particularly steroid-induced avascular necrosis of the femoral head (SANFH). In today's global outbreak, whether corticosteroid therapy should be used, the dosage and duration of treatment, and ways for the prevention, early detection, and timely intervention of SANFH are some important issues that need to be addressed. This review aims to provide a reference for health care providers in COVID-19 endemic countries and regions. Article Focus: Hormones are a double-edged sword. This review aims to provide a reference for health care providers in coronavirus disease 2019 (COVID-19) endemic countries and regions, especially with respect to the pros and cons of corticosteroid use in the treatment of patients with COVID-19. Key Messages: In today's global outbreak, whether corticosteroid therapy should be used, the dosage and duration of treatment, and ways for the prevention, early detection, and timely intervention of SANFH are some important issues that need to be addressed. Strengths and Limitations: Since SARS was mainly prevalent in China at that time, many evidences in this paper came from the reports of Chinese scholars. There is a bias in the selection of data, which may ignore the differences in environment, race, living habits, medical level and so on. SANFH may be the result of multiple factors. Whether the virus itself is an independent risk factor for SANFH has not been confirmed. In this paper, through literature retrieval, some reference opinions on glucocorticoid usage, diagnosis and treatment of SANFH are given. However, due to the lack of large-scale research data support, it can not be used as the gold standard for the above problems.read more
Citations
More filters
Journal ArticleDOI
Knowledge structure and emerging trends on osteonecrosis of the femoral head: a bibliometric and visualized study
TL;DR: Wang et al. as mentioned in this paper attempted to summarize the comprehensive knowledge map, development landscape, and future directions of osteonecrosis of the femoral head (ONFH) research with the bibliometric approach.
Journal ArticleDOI
Aggressive Presentation and Rapid Progression of Osteonecrosis of the Femoral Head After COVID-19
P Dhanasekararaja,Dhanasekaran Soundarrajan,Kanugula Sandeep Kumar,B. T. Pushpa,Natesan Rajkumar,S. Rajasekaran +5 more
TL;DR: In this article , the consecutive patients diagnosed with osteonecrosis of femoral head (ONFH) following recovery from COVID-19 disease and elucidate the unique features of ONFH associated with COVID19.
Journal ArticleDOI
Musculoskeletal Manifestations of COVID-19: Currently Described Clinical Symptoms and Multimodality Imaging Findings
TL;DR: Imaging findings for various COVID-19–related MSK pathologic conditions across a variety of modalities are being recognized, which can be helpful for diagnosis, treatment guidance, and follow-up.
Journal ArticleDOI
Aggressive Presentation and Rapid Progression of Osteonecrosis of the Femoral Head After COVID-19
P Dhanasekararaja,Dhanasekaran Soundarrajan,Kanugula Sandeep Kumar,B. T. Pushpa,Natesan Rajkumar,S. Rajasekaran +5 more
TL;DR: In this article , the consecutive patients diagnosed with osteonecrosis of femoral head (ONFH) following recovery from COVID-19 disease and elucidate the unique features of ONFH associated with COVID19.
Journal ArticleDOI
Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence.
Riccardo Sarzani,Francesco Spannella,Federico Giulietti,Chiara Di Pentima,Piero Giordano,Andrea Giacometti +5 more
TL;DR: In this article, the role of immune response in viral infections, especially SARS-CoV-2, and discuss the potential harms of glucocorticoid drugs misuse in COVID-19.
References
More filters
Journal ArticleDOI
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
TL;DR: The current understanding of how a dysregulated immune response may cause lung immunopathology leading to deleterious clinical manifestations after pathogenic hCoV infections is reviewed.
Journal ArticleDOI
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
Sterne Jac.,Srinivas Murthy,Janet V. Diaz,Arthur S. Slutsky,Judit Villar,Derek C. Angus,Djillali Annane,Azevedo Lcp.,Otavio Berwanger,Alexandre Biasi Cavalcanti,Dequin P-F.,Dequin P-F.,Bin Du,Jonathan Emberson,David Fisher,Bruno Giraudeau,Anthony C. Gordon,Anders Granholm,Cameron Green,Richard Haynes,N Heming,Higgins Jpt.,Higgins Jpt.,Peter Horby,Peter Jüni,Martin J Landray,A. Le Gouge,Marie Leclerc,Wei Shen Lim,Flávia Ribeiro Machado,Colin McArthur,Colin McArthur,Ferhat Meziani,Morten Hylander Møller,Anders Perner,M W Petersen,Jelena Savović,Jelena Savović,Bruno Martins Tomazini,Viviane C Veiga,Steven A R Webb,John C. Marshall +41 more
TL;DR: A prospective meta-analysis that pooled data from 7 randomized clinical trials that evaluated the efficacy of corticosteroids in 1703 critically ill patients with COVID-19 found that low-dose dexamethasone reduced mortality in hospitalized patients with Cohen's disease who required respiratory support.
Journal ArticleDOI
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
TL;DR: The 2019 novel coronavirus (2019-nCoV) outbreak is a major challenge for clinicians as little data is available that describe the disease pathogenesis, and no pharmacological therapies of proven efficacy yet exist, so understanding the evidence for harm or benefit from corticosteroids in 2019-n coV is of immediate clinical importance.
Journal ArticleDOI
SARS: Systematic Review of Treatment Effects
TL;DR: It was not possible to determine whether treatments benefited patients during the SARS outbreak, but clinical trials should be designed to validate a standard protocol for dosage and timing and to accrue data in real time during future outbreaks to monitor specific adverse effects and help inform treatment.
Journal ArticleDOI
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy
Dora Liu,Alexandra Ahmet,Leanne M Ward,Preetha Krishnamoorthy,Efrem D. Mandelcorn,Richard Leigh,Jacques P. Brown,Albert Cohen,Harold Kim,Harold Kim +9 more
TL;DR: This comprehensive article reviews these adverse events of systemic corticosteroid therapy and provides practical recommendations for their prevention and management based on both current literature and the clinical experience of the authors.